Summit Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $395k | 151k | 2.61 |
| 2023-09-30 | $183k | 98k | 1.88 |
| 2023-06-30 | $131k | 52k | 2.51 |
| 2023-03-31 | $284k | 162k | 1.75 |
| 2022-12-31 | $10k | 2.4k | 4.25 |
| 2022-09-30 | $49k | 49k | 0.99 |
| 2022-06-30 | $60k | 63k | 0.95 |
| 2022-03-31 | $201k | 82k | 2.45 |
| 2021-12-31 | $313k | 116k | 2.69 |
| 2021-09-30 | $623k | 124k | 5.01 |
| 2021-06-30 | $931k | 125k | 7.46 |
| 2021-03-31 | $739k | 126k | 5.87 |
| 2020-12-31 | $640k | 138k | 4.63 |
| 2020-09-30 | $485k | 141k | 3.44 |